Next Article in Journal
Histochemical and Microscopic Studies Predict that Grapevine Genotype “Ju mei gui” is Highly Resistant against Botrytis cinerea
Next Article in Special Issue
In Vivo Antimicrobial and Wound-Healing Activity of Resveratrol, Dihydroquercetin, and Dihydromyricetin against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans
Previous Article in Journal
Persistent Calyxes in Postbloom Fruit Drop: A Microscopy and Microanalysis Perspective
Previous Article in Special Issue
Cerebral HSV-1 Vasculitis as a Fatal Complication of Immunosuppression in Non-Hodgkin´s Lymphoma: A Case Report and Review of the Literature
Open AccessReview

Inflammasomes as Targets for Adjuvants

Kazan Federal University, 420008 Kazan, Russia
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia
University of Nevada, Reno, NV 89557, USA
Author to whom correspondence should be addressed.
Pathogens 2020, 9(4), 252;
Received: 2 March 2020 / Revised: 27 March 2020 / Accepted: 28 March 2020 / Published: 30 March 2020
(This article belongs to the Special Issue Biomarkers and Pathogenesis of Infectious and Autoimmune Diseases)
Inflammasomes are an essential part of the innate immune system. They are necessary for the development of a healthy immune response against infectious diseases. Inflammasome activation leads to the secretion of pro-inflammatory cytokines such as IL-1β and IL-18, which stimulate the adaptive immune system. Inflammasomes activators can be used as adjuvants to provide and maintain the strength of the immune response. This review is focused on the mechanisms of action and the effects of adjuvants on inflammasomes. The therapeutic and prophylaxis significance of inflammasomes in infectious diseases is also discussed. View Full-Text
Keywords: vaccines; adjuvants; inflammasomes; innate immunity; cytokines vaccines; adjuvants; inflammasomes; innate immunity; cytokines
Show Figures

Figure 1

MDPI and ACS Style

Ivanov, K.; Garanina, E.; Rizvanov, A.; Khaiboullina, S. Inflammasomes as Targets for Adjuvants. Pathogens 2020, 9, 252.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop